Molecular Epidemiology of HIV-1 Infected Migrants Followed Up in Portugal: Trends between 2001–2017
暂无分享,去创建一个
Pieter J. K. Libin | P. Libin | A. Vandamme | R. Camacho | M. O. Martins | A. Abecasis | A. Pineda-Peña | S. Fernandes | M. Pingarilho | V. Pimentel | Mafalda Miranda | P. Gómes | I. Diogo | Daniela Alves | M. Martins | Mafalda N S Miranda | Rosário O. Martins
[1] L. P. Coelho,et al. Prevalence of HIV-1 transmitted drug resistance and viral suppression among recently diagnosed adults in São Paulo, Brazil , 2019, Archives of Virology.
[2] Ibrahim Abubakar,et al. Global patterns of mortality in international migrants: a systematic review and meta-analysis , 2018, The Lancet.
[3] F. Månsson,et al. Prevalence of HIV-1 pretreatment drug resistance among treatment naïve pregnant women in Bissau, Guinea Bissau , 2018, PloS one.
[4] K. Pottie,et al. The Effectiveness and Cost-Effectiveness of Screening for HIV in Migrants in the EU/EEA: A Systematic Review , 2018, International journal of environmental research and public health.
[5] R. Shafer,et al. Human Immunodeficiency Virus Drug Resistance: 2018 Recommendations of the International Antiviral Society–USA Panel , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[6] M. Prosperi,et al. The global burden of HIV-1 drug resistance in the past 20 years , 2018, PeerJ.
[7] D. Pizzol,et al. Health-care services for young people with HIV in Mozambique. , 2018, The Lancet. Child & adolescent health.
[8] J. Albert,et al. Increase in transmitted drug resistance in migrants from sub-Saharan Africa diagnosed with HIV-1 in Sweden , 2018, AIDS.
[9] Ann Nowé,et al. The impact of HIV-1 within-host evolution on transmission dynamics. , 2018, Current opinion in virology.
[10] B. Brenner,et al. Genotypic and Phylogenetic Insights on Prevention of the Spread of HIV-1 and Drug Resistance in “Real-World” Settings , 2017, Viruses.
[11] Tulio de Oliveira,et al. HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis , 2017, The Lancet. Infectious diseases.
[12] N. Bannert,et al. Temporal trends of transmitted HIV drug resistance in a multinational seroconversion cohort , 2017, AIDS.
[13] E. Maltezos,et al. Transmission Dynamics of HIV-1 Drug Resistance among Treatment-Naïve Individuals in Greece: The Added Value of Molecular Epidemiology to Public Health , 2017, Genes.
[14] Á. Holguín,et al. Trends in Drug Resistance Prevalence, HIV-1 Variants and Clinical Status in HIV-1-infected Pediatric Population in Madrid: 1993 to 2015 Analysis , 2017, The Pediatric infectious disease journal.
[15] J. Ussher,et al. Refugee and migrant women's engagement with sexual and reproductive health care in Australia: A socio-ecological analysis of health care professional perspectives , 2017, PloS one.
[16] R. Shafer,et al. HIV-1 drug resistance and resistance testing. , 2016, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.
[17] V. Veloso,et al. Impact of HIV-1 Subtypes on AIDS Progression in a Brazilian Cohort. , 2016, AIDS research and human retroviruses.
[18] R. Shafer,et al. Surveillance of HIV Transmitted Drug Resistance in Latin America and the Caribbean: A Systematic Review and Meta-Analysis , 2016, PloS one.
[19] Programa Nacional para a Infeção Vih,et al. Infeção VIH/SIDA: a situação em Portugal a 31 de dezembro de 2014 , 2015 .
[20] A. Tanuri,et al. Trends in Prevalence of HIV-1 Drug Resistance in a Public Clinic in Maputo, Mozambique , 2015, PloS one.
[21] K. Anderson,et al. Current Perspectives on HIV-1 Antiretroviral Drug Resistance , 2014, Viruses.
[22] H. Stellbrink,et al. Estimating Trends in the Proportion of Transmitted and Acquired HIV Drug Resistance in a Long Term Observational Cohort in Germany , 2014, PloS one.
[23] Glenn Lawyer,et al. COMET: adaptive context-based modeling for ultrafast HIV-1 subtype identification , 2014, Nucleic acids research.
[24] A. Marques,et al. HIV Risky Sexual Behaviors and HIV Infection Among Immigrants: A Cross-Sectional Study in Lisbon, Portugal , 2014, International journal of environmental research and public health.
[25] A. Vicente,et al. Profile of the HIV Epidemic in Cape Verde: Molecular Epidemiology and Drug Resistance Mutations among HIV-1 and HIV-2 Infected Patients from Distinct Islands of the Archipelago , 2014, PloS one.
[26] H. Günthard,et al. Treatment-naive individuals are the major source of transmitted HIV-1 drug resistance in men who have sex with men in the Swiss HIV Cohort Study. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[27] Anne-Mieke Vandamme,et al. Automated subtyping of HIV-1 genetic sequences for clinical and surveillance , 2013 .
[28] A. Tanuri,et al. Evolution of Primary HIV Drug Resistance in a Subtype C Dominated Epidemic in Mozambique , 2013, PloS one.
[29] Jean Ruelle,et al. RegaDB: community-driven data management and analysis for infectious diseases , 2013, Bioinform..
[30] G. Bello,et al. HIV-1 Genetic Diversity and Transmitted Drug Resistance Mutations among Patients from the North, Central and South Regions of Angola , 2012, PloS one.
[31] F. Hamers,et al. The epidemiology of HIV and AIDS reports in migrants in the 27 European Union countries, Norway and Iceland: 1999-2006. , 2011, European journal of public health.
[32] A. Tanuri,et al. Frequency of primary resistance to antiretroviral drugs and genetic variability of HIV-1 among infected pregnant women recently diagnosed in Luanda-Angola. , 2010, AIDS research and human retroviruses.
[33] A. Vandamme,et al. Effect of human immunodeficiency virus type 1 protease inhibitor therapy and subtype on development of resistance in subtypes B and G. , 2010, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.
[34] Tulio de Oliveira,et al. A standardized framework for accurate, high-throughput genotyping of recombinant and non-recombinant viral sequences , 2009, Nucleic Acids Res..
[35] Anne-Mieke Vandamme,et al. Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update , 2009, PloS one.
[36] M. Peeters,et al. Evaluation of transmitted HIV drug resistance among recently-infected antenatal clinic attendees in four Central African countries , 2008, Antiviral therapy.
[37] G. Bello,et al. Demographic history of HIV-1 subtypes B and F in Brazil. , 2007, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.
[38] Ming Zhang,et al. jpHMM at GOBICS: a web server to detect genomic recombinations in HIV-1 , 2006, Nucleic Acids Res..
[39] A. Vandamme,et al. HIV-1 genetic variants circulation in the North of Angola. , 2005, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.
[40] Ester C Sabino,et al. Brazilian Network for HIV Drug Resistance Surveillance (HIV-BResNet): a survey of chronically infected individuals , 2003, AIDS.
[41] G. Learn,et al. Distribution of HIV‐1 subtypes seen in an AIDS clinic in Sao Paulo City, Brazil , 1996, AIDS.
[42] Ross J. Harris,et al. Enhanced surveillance of HIV-1 drug resistance in recently infected MSM in the UK , 2017, The Journal of antimicrobial chemotherapy.
[43] E. Arts,et al. Tracking a century of global expansion and evolution of HIV to drive understanding and to combat disease. , 2011, The Lancet. Infectious diseases.